176 related articles for article (PubMed ID: 17671687)
21. Effects of phenylethyl isothiocyanate and its metabolite on cell-cycle arrest and apoptosis in LNCaP human prostate cancer cells.
Hwang ES; Lee HJ
Int J Food Sci Nutr; 2010 May; 61(3):324-36. PubMed ID: 20402549
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
Liang YC; Lin-Shiau SY; Chen CF; Lin JK
J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
[TBL] [Abstract][Full Text] [Related]
23. Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3.
Jiang J; Slivova V; Valachovicova T; Harvey K; Sliva D
Int J Oncol; 2004 May; 24(5):1093-9. PubMed ID: 15067330
[TBL] [Abstract][Full Text] [Related]
24. ProstaCaid induces G2/M cell cycle arrest and apoptosis in human and mouse androgen-dependent and-independent prostate cancer cells.
Yan J; Katz AE
Integr Cancer Ther; 2010 Jun; 9(2):186-96. PubMed ID: 20587444
[TBL] [Abstract][Full Text] [Related]
25. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-8 signaling promotes translational regulation of cyclin D in androgen-independent prostate cancer cells.
MacManus CF; Pettigrew J; Seaton A; Wilson C; Maxwell PJ; Berlingeri S; Purcell C; McGurk M; Johnston PG; Waugh DJ
Mol Cancer Res; 2007 Jul; 5(7):737-48. PubMed ID: 17606477
[TBL] [Abstract][Full Text] [Related]
27. Bombesin regulates cyclin D1 expression through the early growth response protein Egr-1 in prostate cancer cells.
Xiao D; Chinnappan D; Pestell R; Albanese C; Weber HC
Cancer Res; 2005 Nov; 65(21):9934-42. PubMed ID: 16267018
[TBL] [Abstract][Full Text] [Related]
28. Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53.
Vikhanskaya F; Erba E; D'Incalci M; Broggini M
Exp Cell Res; 1996 Sep; 227(2):380-5. PubMed ID: 8831577
[TBL] [Abstract][Full Text] [Related]
29. Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2.
Chang HL; Wu YC; Su JH; Yeh YT; Yuan SS
J Pharmacol Exp Ther; 2008 Jun; 325(3):841-9. PubMed ID: 18337475
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol.
Carlson B; Lahusen T; Singh S; Loaiza-Perez A; Worland PJ; Pestell R; Albanese C; Sausville EA; Senderowicz AM
Cancer Res; 1999 Sep; 59(18):4634-41. PubMed ID: 10493518
[TBL] [Abstract][Full Text] [Related]
31. 15-deoxy-Delta(12,14)-prostaglandin J2 inhibits G2-M phase progression in human breast cancer cells via the down-regulation of cyclin B1 and survivin expression.
Kamagata C; Tsuji N; Moriai M; Kobayashi D; Watanabe N
Breast Cancer Res Treat; 2007 May; 102(3):263-73. PubMed ID: 17028981
[TBL] [Abstract][Full Text] [Related]
32. A novel anticancer agent, retigeric acid B, displays proliferation inhibition, S phase arrest and apoptosis activation in human prostate cancer cells.
Liu H; Liu YQ; Liu YQ; Xu AH; Young CY; Yuan HQ; Lou HX
Chem Biol Interact; 2010 Dec; 188(3):598-606. PubMed ID: 20692244
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanisms for apigenin-induced cell-cycle arrest and apoptosis of hormone refractory human prostate carcinoma DU145 cells.
Shukla S; Gupta S
Mol Carcinog; 2004 Feb; 39(2):114-26. PubMed ID: 14750216
[TBL] [Abstract][Full Text] [Related]
34. Transient suppression of nuclear Cdc2 activity in response to ionizing radiation.
Kim MJ; Lee JY; Lee SJ
Oncol Rep; 2008 May; 19(5):1323-9. PubMed ID: 18425394
[TBL] [Abstract][Full Text] [Related]
35. IFNalpha induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells.
Hobeika AC; Subramaniam PS; Johnson HM
Oncogene; 1997 Mar; 14(10):1165-70. PubMed ID: 9121765
[TBL] [Abstract][Full Text] [Related]
36. The inhibitory effects of gossypol on human prostate cancer cells-PC3 are associated with transforming growth factor beta1 (TGFbeta1) signal transduction pathway.
Jiang J; Sugimoto Y; Liu S; Chang HL; Park KY; Kulp SK; Lin YC
Anticancer Res; 2004; 24(1):91-100. PubMed ID: 15015581
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV
Exp Cell Res; 2001 Apr; 265(1):152-66. PubMed ID: 11281653
[TBL] [Abstract][Full Text] [Related]
38. Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft.
Gregory CW; Johnson RT; Presnell SC; Mohler JL; French FS
J Androl; 2001; 22(4):537-48. PubMed ID: 11451350
[TBL] [Abstract][Full Text] [Related]
39. PM-3, a benzo-gamma-pyran derivative isolated from propolis, inhibits growth of MCF-7 human breast cancer cells.
Luo J; Soh JW; Xing WQ; Mao Y; Matsuno T; Weinstein IB
Anticancer Res; 2001; 21(3B):1665-71. PubMed ID: 11497245
[TBL] [Abstract][Full Text] [Related]
40. Suppressive effects of ethanolic extracts from propolis and its main botanical origin on dioxin toxicity.
Park YK; Fukuda I; Ashida H; Nishiumi S; Yoshida K; Daugsch A; Sato HH; Pastore GM
J Agric Food Chem; 2005 Dec; 53(26):10306-9. PubMed ID: 16366731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
